<DOC>
	<DOCNO>NCT02629926</DOCNO>
	<brief_summary>Cure rate childhood malignancy improve remarkable pace.With increase cure rate come recognition long-term detrimental effect radiotherapy chemotherapy , know `` late-effects '' . Endocrine late-effects particularly prevalent childhood cancer survivor . Growth Hormone ( GH ) deficiency common follow radiation head lead impaired growth , hence GH replacement give achieve optimise final height childhood . In adult GH important maintenance bone , muscle &amp; fat mass; vascular risk factors; quality life . This observational study aim determine long-term effect low dose GH replacement development bone , muscle fat mass; vascular risk; quality life early year achievement final height , time know `` transition '' . GH think essential development bone , muscle , fat mass time period . Patients identify late -effects endocrine clinic , age 16-22yrs , severely GH deficient . 30 patient recruit study wish continue receive GH replacement , receive recombinant GH . An additional 30 patient wish receive GH replacement provide parallel control data . All patient undergo baseline assessment include examination; routine blood tests; urine dipstick; measure height , weight , waist , 24 hour blood pressure . Measures repeat six month , annually 25 year age . Bone density measure baseline , two year age 25yrs . Patients request GH replacement require initial additional visit teach self injection , 2-4wkly ass correct dose GH achieve . The study enable assessment beneficial effect GH replacement transition GH deficient survivor cancer realise .</brief_summary>
	<brief_title>Transitional Growth Hormone ( GH ) Use Growth Hormone Deficient ( GHD ) Cancer Survivors</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Aged 1622 year inclusive . Both gender . Able provide inform consent . Severe GH deficiency ( peak GH &lt; 5mcg/l stimulation ) . No GH replacement therapy three month precede baseline visit . Stable anterior pituitary hormone ( i.e . sex steroid , hydrocortisone , thyroxine ) therapy previous six month . Life expectancy &gt; 24 month . Acute critical illness ( Patients suffer complication follow open heart surgery , abdominal surgery , multiple accidental trauma , acute respiratory failure , similar condition ) . Active malignant disease ( i.e . undergo active treatment palliation ) . Patients treat intracranial malignancy complete therapy two year prior enter study . Active Cushing 's disese acromegaly Pregnancy desire conceive within follow year . Patients risk pregnancy screen urine pregnancy ( HCG ) test baseline evaluation &amp; treatment initiation visit . Breast feeding . Proliferative diabetic retinopathy . Sensitivity GH preservative</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>